Home › Hemophilia › North Carolina
Hemophilia clinical trials in North Carolina
6 studies for Hemophilia are looking for participants at sites in North Carolina.
Cities in North Carolina
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Duke University Health System, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill
- St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital, Charlotte
- East Carolina University Hemophilia Treatment Center, Greenville
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated Aug 17, 2026 · NCT04398628A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Brody School of Medicine at East Carolina University, Greenville
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Jul 2, 2026 · NCT06349473A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
- Brody School of Medicine at East Carolina University, Greenville
- ECU Health Medical Center, Greenville
RecruitingPhase 1
Ages 12 to 74 · Men · Updated Jun 3, 2026 · NCT06703606ATHNdataset Registry
- American Thrombosis and Hemostasis Network, Hickory
RecruitingObservational study
All ages · All sexes · Updated Apr 21, 2026 · NCT06820515SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Brody School of Medicine at East Carolina University, Greenville
RecruitingPhase 4
Ages 12 to 100 · All sexes · Updated Jan 12, 2026 · NCT04647227From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.